Abstract
The Buddhist Lent (known as War Dwin in Myanmar) is a 3 lunar month long period of fasting observed by devout Buddhist during the monsoon each summer. Dietary patterns during the War Dwin pose a challenge for patients with diabetes who wish to fast, as well as for diabetes care providers who have to provide effective, yet safe therapeutic regimes. During the War Dwin, people take solid meals only from midnight to noon. Intake is limited to jaggery and from noon to midnight. This predisposes to hypoglycemia, which in turn encourages defensive snacking and leads to poor glycemic control. This article discusses rational oral drug therapeutic options during War Dwin. It draws from available pharmacological evidence, combined with clinical experience, to suggest possible antidiabetic regimes which combine efficacy with safety and tolerability. DOI: http://dx.doi.org/10.4038/sjdem.v3i2.6380 Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2013; 3 : 108-111
Highlights
Buddhism is one of the major world religions, and has adherents in every continent of the world
Oral drug modification during Buddhist Lent. Another clinical scenario that often occurs is decompensation of glycemic control Buddhist Lent, in a patient who was previously well controlled on Oral antidiabetic drug (OAD)
The framework presented in this table encourages diabetes care professional to follow a rational approach to OAD modification during the fasting month
Summary
Buddhism is one of the major world religions, and has adherents in every continent of the world It is the main religion of a large number of Asian countries, including Sri Lanka, Bhutan, Myanmar, Thailand, Laos, Cambodia, and Vietnam. The Buddhist Lent (known as War Dwin in Myanmar) is 3 lunar month long annual period of fasting observed by devout Buddhists during every monsoon. This poses a special health challenge for people with diabetes who wish to observe the fast, and follow a specific dietary restriction associated with it. Healthcare providers, are often not sensitized to the specific needs and requirement for this patient population This communication tries to address this issue.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Sri Lanka Journal of Diabetes Endocrinology and Metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
